US5830653A — Methods of using oligomers containing modified py…

Claim 1

Independent Claim 124 words

A method to evaluate a candidate antisense oligomer for its ability to inhibit gene expression, which method comprises: microinjecting varying amounts of said candidate antisense oligomer into a host cell along with (a) a target vector for the expression of a gene containing a target sequence for said candidate antisense oligomer, and (b) a control vector for the expression of a control gene encoding a detectable protein, wherein said control gene does not contain said target sequence; and measuring expression of the target gene and the control gene; wherein increasing inhibition of the target gene expression, but not of the control gene expression, as the amount of said candidate antisense oligomer increases, indicates the ability of said candidate antisense oligomer to inhibit gene expression.

Claim 2

Independent Claim 124 words

A method to evaluate a candidate antisense oligomer for its ability to inhibit gene expression, which method comprises: microinjecting varying amounts of said candidate antisense oligomer into a host cell along with (a) a target vector for the expression of a gene containing a target sequence for said candidate antisense oligomer, and (b) a control vector for the expression of a control gene encoding a detectable protein, wherein said control gene does not contain said target sequence; and measuring expression of the target gene and the control gene; wherein increasing inhibition of the target gene expression, but not of the control gene expression, as the amount of said candidate antisense oligomer increases, indicates the ability of said candidate antisense oligomer to inhibit gene expression.

Claim 3

Dependent Claim 29 words

The method of claim 1 wherein said target vector is injected at about 2-4 copies per cell and said control vector is injected at about 30-50 copies per cell.

Claim 4

Dependent Claim 16 words

The method of claim 1 wherein said detectable protein is chloramphenicol acetyl transferase, luciferase or β-galactosidase.

Claim 5

Dependent Claim 13 words

The method of claim 1 wherein said host cell is a mammalian cell.

Claim 6

Dependent Claim 15 words

The method of claim 2 wherein said detectable protein is chloramphenicol acetyltransferase, luciferase or β-galactosidase.

Claim 7

Dependent Claim 17 words

The method of claim 2 wherein the candidate antisense oligomer comprises a phosphorothioate or a phosphodiester linkage.

Claim 8

Dependent Claim 26 words

The method of claim 6 wherein the candidate antisense oligomer comprises a base selected from the group consisting of adenine, guanine, cytosine, 5-methylcytosine, thymine and uracil.

Claim 9

Dependent Claim 170 words

The method of claim 6 wherein the candidate antisense oligomer comprises a base of formula (1) or (2) ##STR11## wherein each X is independently O or S; and R 2 is cyano, or R 2 is C 2-12 1-alkynyl optionally substituted with halogen or an alkynyl group, R 2 is C 2-12 1-alkenyl optionally substituted with halogen or an alkynyl group, or R 2 is a C 2-12 heteroaromatic group containing 5-6 ring atoms in which one to three of the ring atoms independently is nitrogen, oxygen or sulfur, whrein the heteroatromatic group is optionally substituted on a ring carbon atom by oxygen, halogen or C 1-4 alkyl or substituted on a ring nitrogen by C 1-4 alkyl, or R 2 is --C.tbd.C--Z wherein Z is hydrogen or C 1-10 alkyl or C 1-10 haloalkyl with 1 to 6 halogen atoms, or Z is a (1-alkynyl)-heteroaromatic group optionally substituted on a ring carbon by oxygen or C 1-4 alkyl or optionally substituted on a ring nitrogen by C 1-4 alkyl.

Claim 10

Dependent Claim 13 words

The method of claim 8 wherein R 2 is 1-propynyl, 1-butynyl or 2-thiazolyl.

Claim 11

Dependent Claim 14 words

The method of claim 8 wherein the candidate antisense oligomer comprises a phosphorothioate linkage.

Claim 12

Independent Claim 286 words

A method of inhibiting the expression of at least one selected protein in a cell, wherein the protein is translated from RNA, the method comprising the steps of: introducing into the cell an oligomer comprising at least 8 nucleomonomers wherein at least one of the nucleomonomers comprises a base of formula (1) or (2) ##STR12## wherein each X is independently O or S; R 2 is cyano, or R 2 is C 2-12 1-alkynyl optionally substituted with halogen or an alkynyl group, or R 2 is C 2-12 1-alkenyl optionally substituted with halogen or an alkynyl group, or R 2 is a C 2-12 heteroaromatic group containing 5-6 ring atoms in which one to three of the ring atoms independently is nitrogen, oxygen or sulfur, wherein the heteroaromatic group is optionally substituted on a ring carbon atom by oxygen, halogen or C 1-4 alkyl or substituted on a ring nitrogen by C 1-4 alkyl, or R 2 is --C.tbd.C--Z wherein Z is hydrogen or C 1-10 alkyl or C 1-10 haloalkyl with 1 to 6 halogen atoms, or Z is a (1-alkynyl)-heteroaromatic group optionally substituted on a ring carbon by oxygen or C 1-4 alkyl or optionally substituted on a ring nitrogen by C 1-4 alkyl; Pr is (H) 2 or a protecting group, with the proviso that when at least one of the nucleomonomers of the oligomer comprises deoxyuridine 5-substituted by vinyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 1-heptenyl, 1-octenyl, 1-propynyl, 1-butynyl, 1-hexynyl, 1-heptynyl, or 1-octynyl, then the remainder of the nucleomonomers comprising the oligomer are not solely comprised of phosphodiester linked 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, thymidine or a combination thereof; and permitting the oligomer to form a duplex with the RNA whereby expression of the protein is inhibited.

Claim 13

Independent Claim 286 words

A method of inhibiting the expression of at least one selected protein in a cell, wherein the protein is translated from RNA, the method comprising the steps of: introducing into the cell an oligomer comprising at least 8 nucleomonomers wherein at least one of the nucleomonomers comprises a base of formula (1) or (2) ##STR12## wherein each X is independently O or S; R 2 is cyano, or R 2 is C 2-12 1-alkynyl optionally substituted with halogen or an alkynyl group, or R 2 is C 2-12 1-alkenyl optionally substituted with halogen or an alkynyl group, or R 2 is a C 2-12 heteroaromatic group containing 5-6 ring atoms in which one to three of the ring atoms independently is nitrogen, oxygen or sulfur, wherein the heteroaromatic group is optionally substituted on a ring carbon atom by oxygen, halogen or C 1-4 alkyl or substituted on a ring nitrogen by C 1-4 alkyl, or R 2 is --C.tbd.C--Z wherein Z is hydrogen or C 1-10 alkyl or C 1-10 haloalkyl with 1 to 6 halogen atoms, or Z is a (1-alkynyl)-heteroaromatic group optionally substituted on a ring carbon by oxygen or C 1-4 alkyl or optionally substituted on a ring nitrogen by C 1-4 alkyl; Pr is (H) 2 or a protecting group, with the proviso that when at least one of the nucleomonomers of the oligomer comprises deoxyuridine 5-substituted by vinyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 1-heptenyl, 1-octenyl, 1-propynyl, 1-butynyl, 1-hexynyl, 1-heptynyl, or 1-octynyl, then the remainder of the nucleomonomers comprising the oligomer are not solely comprised of phosphodiester linked 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, thymidine or a combination thereof; and permitting the oligomer to form a duplex with the RNA whereby expression of the protein is inhibited.

Claim 14

Dependent Claim 38 words

The method of claim 11 wherein the oligomer is introduced into the cell by a method selected from the group consisting of calcium phosphate transfection, DMSO transfection, dextran transfection, cationic lipid transfection, anionic lipid transfection and liposome transfection.

Claim 15

Dependent Claim 44 words

The method of claim 11 wherein the RNA has a translocation junction, is a virally encoded RNA, or encodes a product selected from the group consisting of enzymes, hormones, serum proteins, adhesion molecules, receptor molecules, cytokines, oncogenes, growth factors, interleukins, mitogens, and MHC molecules.

Claim 16

Dependent Claim 19 words

The method of claim 13 wherein R 2 is selected from the group consisting of 1-propynyl, 1-butynyl and 2-thiazolyl.

Claim 17

Independent Claim 272 words

A method of introducing an oligomer into cells, comprising: mixing an oligomer comprising at least 8 nucleomdnomers wherein at least one of the nucleomonomers comprises a base of formula (1) or (2) ##STR13## wherein each X is independently O or S; R 2 is cyano, or R 2 is C 2-12 1-alkynyl optionally substituted with halogen or an alkynyl group, or R 2 is C 2-12 1-alkenyl optionally substituted with halogen or an alkynyl group, or R 2 is a C 2-12 heteroaromatic group containing 5-6 ring atoms in which one to three of the ring atoms independently is nitrogen, oxygen or sulfur, wherein the heteroaromatic group is optionally substituted on a ring carbon atom by oxygen, halogen or C 1-4 alkyl or substituted on a ring nitrogen by C 1-4 alkyl, or R 2 is --C.tbd.C--Z wherein Z is hydrogen or C 1-10 alkyl or C 1-10 haloakyl with 1 to 6 halogen atoms, or Z is a (1-alkynyl)-heteroaromatic group olptionally substituted on a ring carbon by oxygen or C 1-4 alkyl or optionally substituted on a ring nitrogen by C 1-4 alkyl; Pr is (H) 2 or a protecting group, with the proviso that when at least one of the nucleomonomers of the oligomer comprises deoxyuridine 5-substituted by vinyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 1-heptenyl, 1-octenyl, 1-propynyl, 1-butynyl, 1-hexynyl, 1-heptynyl, or 1-octynyl, then the remainder of the nucleomonomers comprising the oligomer are not solely comprised of phosphodiester linked 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, thymidine or a combination thereof, with a permeation enhancing agent to form a complex; and incubating the complex with the cells under conditions where the complex is introduced into the cells.

Claim 18

Independent Claim 272 words

A method of introducing an oligomer into cells, comprising: mixing an oligomer comprising at least 8 nucleomdnomers wherein at least one of the nucleomonomers comprises a base of formula (1) or (2) ##STR13## wherein each X is independently O or S; R 2 is cyano, or R 2 is C 2-12 1-alkynyl optionally substituted with halogen or an alkynyl group, or R 2 is C 2-12 1-alkenyl optionally substituted with halogen or an alkynyl group, or R 2 is a C 2-12 heteroaromatic group containing 5-6 ring atoms in which one to three of the ring atoms independently is nitrogen, oxygen or sulfur, wherein the heteroaromatic group is optionally substituted on a ring carbon atom by oxygen, halogen or C 1-4 alkyl or substituted on a ring nitrogen by C 1-4 alkyl, or R 2 is --C.tbd.C--Z wherein Z is hydrogen or C 1-10 alkyl or C 1-10 haloakyl with 1 to 6 halogen atoms, or Z is a (1-alkynyl)-heteroaromatic group olptionally substituted on a ring carbon by oxygen or C 1-4 alkyl or optionally substituted on a ring nitrogen by C 1-4 alkyl; Pr is (H) 2 or a protecting group, with the proviso that when at least one of the nucleomonomers of the oligomer comprises deoxyuridine 5-substituted by vinyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 1-heptenyl, 1-octenyl, 1-propynyl, 1-butynyl, 1-hexynyl, 1-heptynyl, or 1-octynyl, then the remainder of the nucleomonomers comprising the oligomer are not solely comprised of phosphodiester linked 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, thymidine or a combination thereof, with a permeation enhancing agent to form a complex; and incubating the complex with the cells under conditions where the complex is introduced into the cells.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	2001-11-02	2002-05-04	2002-11-03	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2005-11-02	2006-05-04	2006-11-03	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2009-11-02	2010-05-04	2010-11-03	$7700.00	Window Closed / Lapsed

Methods of using oligomers containing modified pyrimidines

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag